University of Colorado Cancer Center
ASCO® 2023 Insights: "Effect of CBM588 in Combination With Cabozantinib + Nivolumab for Patients With mRCC - A Randomized Clinical Trial"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Hedyeh Ebrahimi
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Hedyeh Ebrahimi
Login to view comments.
Click here to Login
Videos